# Moon Surgical

Canonical page: https://technooptimist.io/companies/moon-surgical
Franco-American company, founded in 2020 and based in Paris and San Francisco, making Maestro: a bedside robot that holds the camera and retractors in keyhole surgery so the surgeon works with their usual instruments.

## In brief

- Maestro is an assistant, not a replacement robot: two arms hold the camera and instruments while the surgeon operates normally.
- ScoPilot (FDA-cleared Mar 2025) makes the camera follow the surgeon's instrument tip, running on NVIDIA Holoscan.
- Over 1,100 patients treated by March 2025; a dataset of 3,000+ procedures trains its AI (June 2026).

## Facts

- Founded: 2020
- Headquarters: FR, US
- Status: private
- Website: https://www.moonsurgical.com
- Frontiers: [Robotics](https://technooptimist.io/robotics.md) (Keyhole surgery robots), [AI](https://technooptimist.io/ai.md)

## Programs

- [Maestro](https://technooptimist.io/robotics/maestro.md) (Robotics): Deploy; next: Roll-out of v2.7 across installed base (2026). Commercial in the US and Europe; v2.7 software (June 2026) adds automated set-up and AI reports.

## Technical approach

- **Co-manipulation: Arms the surgeon pushes by hand**: The arms unlock when moved and lock in place when let go, with no pedal or voice command, so they act like a steady extra pair of hands.
- **AI on the edge: Vision models run in the OR**: Computer vision runs locally on the robot to track instruments and steer the camera, and to automate set-up.
- **Open platform: Third-party apps**: From v2.7 (June 2026) outside AI apps run on Maestro, starting with automatic operative reports and billing codes.

## Open problems

- **From assistant to autonomy** (active research): Each step of automation (camera control, set-up) needs its own FDA clearance; a change-control plan lets ScoPilot improve without a new filing.
- **Proving the business case** (open): Hospitals must see that an assistant robot saves staff time and money without the full benefits of a complete surgical robot.

## Latest updates

- **9 Jun 2026**: Moon Surgical ships Maestro software 2.7 with automated set-up and the first third-party AI app. Version 2.7 turns Maestro from one AI feature into a platform of several models. ([our story](https://technooptimist.io/stories/moon-surgical-ships-maestro-software-2-7-with-automated-set-up-and-the-ebbc0a25.md) · [original source](https://sofinnovapartners.com/news/moon-surgical-expands-maestro-platform-into-multi-model-physical-ai))
- **18 Mar 2025**: FDA clears Moon Surgical's ScoPilot, an AI feature that makes Maestro's camera follow the surgeon's instrument. The FDA cleared ScoPilot, which lets the laparoscope held by Maestro follow the tip of a chosen instrument on demand. ([our story](https://technooptimist.io/stories/fda-clears-moon-surgical-s-scopilot-an-ai-feature-that-makes-maestro-s-8130f24d.md) · [original source](https://www.prnewswire.com/news-releases/moon-surgical-receives-fda-clearance-for-scopilot-on-maestro-industrys-first-ai-enhanced-intraoperative-capability-powered-by--nvidia-holoscan-302404920.html))

## Partners, customers and investors

- NVIDIA (partner): ScoPilot runs on NVIDIA Holoscan, the first intraoperative AI app on a commercial surgical robot with it.
- Sofinnova Partners (investor): Venture investor; CEO Anne Osdoit is a partner at its MedTech accelerator, MD Start.
- Lee Health (customer): Launched Maestro in July 2025.

## People

- Anne Osdoit, CEO

---

The Techno Optimist tracks every frontier of technology, program by program: https://technooptimist.io/ (a Markdown version of any page: add .md to its URL; site map for agents: https://technooptimist.io/llms.txt).
Data API (JSON, realtime stream): https://technooptimist.io/developers. People read 5 pages free, then Reader $10/month; these Markdown pages are open to agents.